In the world of medical research, clinical trials are a critical component. As the primary method for evaluating the safety and efficacy of new treatments, clinical trials also help researchers discover information about various conditions and innovative new treatments. Clinical trials and medicine continue to progress and advance with the latest technological advancements, and that includes moving with the new era of artificial intelligence (AI).
AI and machine learning are becoming ever-present in various elements of our lives, and medical research is no exception. With multiple use cases, AI is already playing an important role in medical research, particularly clinical trials.
Looking to participate in a clinical trial?
Our clinical trial platform can connect you with trials that match your needs and eligibility. Take the first step towards accessing cutting-edge treatments and start your search today to discover the potential benefits of participating in clinical trials.
Challenges in traditional clinical trials
While clinical trials are an essential part of medical research and critical for evolving medicine and healthcare, they are not without challenges. In traditional clinical trials, researchers can come up against lengthy timelines, high costs, and difficulties in the recruitment and retention of participants, particularly those in diverse populations.
There can also be challenges in data management, leading to inefficiencies and errors which could slow down the trial process or even invalidate the study results. If a trial is subject to a number of challenges throughout, the financial burden on sponsors could continue to grow, while potentially innovative treatments could be delayed from reaching the wider population.
What is AI in clinical trials?
Artificial intelligence (AI) in clinical trials can include several technologies in this space, but typically it refers to machine learning and predictive analytics. AI is commonly used in clinical trials to enhance various stages of the trial process. Researchers using AI can leverage vast datasets and advanced algorithms to automate tasks, identify data trends and patterns, and make strategic data-driven decisions that can improve the accuracy and efficiency of a trial.
How is AI used in clinical trials?
AI can be used in a variety of different ways in a clinical trial, from optimizing the patient recruitment process to analyzing complex trial data. Researchers will decide how AI should be used in the clinical trial during the design process, before ensuring the technology is in place before the trial begins.
During recruitment for a trial, AI can be used to quickly identify suitable participants by analyzing medical records, genetic data, and other relevant data. Throughout the clinical trial, AI can be used to support patients as a chatbot, acting as a source of information for times when researchers are unavailable. AI can also help researchers predict potential outcomes, by monitoring real-time data and identifying trends, while also detecting adverse events early and allowing for more informed decisions.
The importance of AI in clinical trials
AI is an important advancement in technology, and it can be highly beneficial in clinical trials too. When it is integrated into the clinical trial process, AI can revolutionize various aspects of a clinical trial, leading to speedier timeframes and more efficient and accurate processes. Using AI and automation, researchers can streamline the entire clinical trial, speeding up the trial design, recruitment, and data analysis.
Artificial intelligence enables researchers to reduce costs too, by finding efficiencies in the trial and removing unnecessary expenses. It can even help researchers scale a clinical trial by removing manual processes and letting research teams focus on high-level, strategic functions. In essence, AI is highly important in delivering clinical trials that are efficient, accurate, and cost-effective.
The role of machine learning (ML) in clinical trials
Machine learning plays a key role in clinical trials too. As a subset of AI, machine learning enables algorithms to learn from data and make predictions without explicit programming. This means machine learning models can accurately predict patient responses to treatments, identify biomarkers for specific conditions, and even support researchers in designing more efficient trial protocols.
With each dataset, machine learning models learn and improve. This helps to fine-tune clinical trial strategies, enhancing the trial experience for participants and providing the opportunity for more personalized treatment options.
Want to know why clinical trials are so important in shaping the future of medicine? Our in-depth guide highlights their critical role in developing new therapies, advancing medical care, and improving lives.
Applications of AI in clinical trials
There is a wide range of uses for AI in a clinical trial, covering every aspect of the trial process. Whether the objective is to streamline processes, find cost efficiencies, enhance participant diversity, or improve the accuracy of results, there is an AI application to be used.
Patient recruitment and enrollment
One of the most crucial aspects of a clinical trial is the recruitment stage and getting it right. If research teams are unable to find enough participants or a suitable pool of candidates, clinical trials can fall at the first hurdle. Historically, researchers would need to actively recruit participants and manually look through hospital records to find suitable participants. This is time-consuming and not always the most effective method.
With AI, hospital data, genetic data, and electronic health records (EHR) can be analyzed in seconds to find suitable participants. The technology can even create its own eligibility criteria by analyzing available data on the illness and comparing it to the characteristics of the study. This significantly speeds up the recruitment process and can even be more accurate since the risk of human error is eliminated.
AI can also be used to support researchers with their overarching recruitment strategies, analyzing historical recruitment data to predict patient interest and engagement based on certain criteria.
Trial design optimization
AI can use predictive analytics to simulate a range of clinical trial scenarios and outcomes to optimize the trial design. This helps researchers develop adaptive trial protocols capable of adjusting in real time depending on the data. The benefit of using AI to do this is improved efficiency and reduced likelihood of expensive mistakes.
As part of the trial design process, research teams can also use AI to identify relevant biomarkers, dosing strategies, and patient groups. This ensures the trial is tailored for maximum impact and minimal risk to the participant.
Data management and analysis
Even smaller clinical trials will generate vast amounts of data, which all need to be analyzed to establish the outcomes and results of the trial. AI can play a key role in data management by automating data collection, cleaning, and analysis.
AI systems can process complex datasets in real-time, and in seconds, uncovering hidden patterns that provide insights that traditional data management methods may not. By using AI in data management and analysis, researchers can quickly identify trends, leading to greater accuracy and improved decision-making.
Compiling information in decentralized and virtual clinical trials
With virtual and decentralized clinical trials gaining more prevalence, there can be a challenge with data collection and ensuring patient compliance. However, with AI, these problems are easily mitigated. AI programs can assess the quality of data submitted by patients in the first instance, ensuring it is accurate before being accepted. This can be beneficial for both patients and research teams.
AI can also compile and analyze information from various devices, whether it’s wearable technology, mobile devices, apps, or remote monitoring devices, enabling participant progress to be tracked in real time.
Monitoring and adverse event detection
Since treatments in a clinical trial may produce side effects that are not known, patient monitoring and adverse event detection are key, and AI can help researchers with this. Similar to AI’s role in decentralized trials, it can be used to remotely monitor patients in real-time to detect adverse reactions or side effects.
As AI can analyze patient data from a variety of sources, it means patterns can be identified and researchers can be alerted to potential side effects before they become serious. This early detection is imperative for patient safety and enhances the ability to adjust treatment protocols as necessary.
In some research projects, researchers will use biosimulation to conduct human tests digitally, measuring the human reaction to the treatment before it ever reaches human trials. Simulations are based on models and data using AI and machine learning, enabling them to generate predictions that researchers can use to understand more about a treatment’s effects.
Early disease diagnosis
A large part of clinical research is disease prevention and early detection, and AI is already playing a pivotal role in this. Hospitals and medical research institutions have started using the technology to develop disease-detection algorithms. As part of this, AI analyzes clinical trial data and medical records to identify patterns associated with diseases at their earliest stages.
AI algorithms can process a variety of data, including medical imaging, genomic data, and patient history to detect even the most subtle signs of disease, enabling early intervention. By identifying conditions before they fully develop, AI can improve treatment outcomes and support more personalized healthcare options, while also ensuring clinical trials concentrate on the right diseases at the right time.
Benefits of using AI in clinical trials
There are numerous benefits to using AI in clinical trials, from enhanced efficiency and improved accuracy to cost reductions and better trial design. No matter the objective of a trial, the benefits of AI each contribute to improving patient outcomes and ultimately speeding up the development of new treatments.
Accelerated timelines
AI can significantly reduce the duration of a clinical trial by optimizing trial processes including participant recruitment, data analysis, and data monitoring. By using AI to complete mundane or repetitive tasks, time-consuming activities can be reduced to mere days and weeks, enabling faster delivery of treatments to the general public.
Cost efficiency
A key benefit of AI for clinical trial sponsors and research teams is the cost efficiencies it can bring. By automating labor-intensive tasks such as data management, analysis, and protocol design, AI can drastically reduce the operational costs of a trial. Further to this, AI can analyze data to support researchers in effective resource allocation and waste reduction, ultimately lowering the financial burden of drug development.
Improved accuracy
No matter how careful researchers are, there is always a risk of human error in a clinical trial. However, with AI, the ability to analyze vast amounts of complex data with precision can reduce the chance of human error and reveal insights that may have otherwise gone unnoticed. By using AI to analyze data, researchers can deliver more accurate and reliable trial results to enable better decision-making across the entire study.
Broader participant reach
Many clinical trials struggle to recruit the right participants, especially when it comes to geographical limitations and ensuring diverse populations are included. With AI, researchers can expand their recruitment efforts to identify participants from diverse or remote populations using electronic health records, social media, and wearable tech. The use of AI also makes decentralized and virtual clinical trials more effective and accurate.
Limitations and challenges of using AI in clinical trials
Like any change or new technology, AI inevitably will bring challenges and limitations for researchers. The integration of AI into a clinical trial can be difficult, despite its clear advantages and usefulness. To effectively use AI in clinical research, it’s important that research teams understand and mitigate against its limitations.
Ethical and regulatory concerns
As a relatively new and still advancing technology, there are ethical concerns related to AI and patient privacy, data security, and algorithm bias. This is largely because regulatory frameworks for AI in clinical trials are still evolving, meaning compliance and approval processes are often complex and unclear.
HIPAA and patient rights
Under the Health Insurance Portability and Accountability Act (HIPAA), patients have the right to privacy and control over their personal health information (PHI). This includes the right to access their personal health files, petition for corrections, and be informed on how their PHI is disclosed and used.
If AI is used in the participant recruitment element of a clinical trial, it is likely via a third-party organization. This can mean risks to patient privacy and compliance with privacy regulations are increased. To mitigate this, researchers must prioritize compliance with HIPAA and other regulations to ensure patient data is de-identified and protected. This means the benefits of AI can be realized, without jeopardizing patient confidentiality or confidence.
FDA regulations
In clinical trials using AI so far, the FDA has been following an action plan for AI use in software as a medical device. This plan comprises a series of proposed measures that agencies should take in response to stakeholder feedback from an initial outline of regulatory modifications. Further to this, the FDA is also taking steps to ensure the harmonization of Good Machine Learning Practices (GMLP), focusing on removing bias from AI algorithms and enforcing a standardized system for scouring patient health records securely.
Have questions about the ethics of clinical trials? Our thorough guide breaks down the key concerns and rules that ensure safety and transparency in clinical research.
Imperfect databases
Perhaps AI’s biggest obstacle is the inherent bias in research datasets. The successful integration of AI in a clinical trial depends on the quality of the data it is processing, so if that data is incomplete, biased, or inconsistent, the results of the trial may not be accurate. Unfortunately, bad data can lead to inaccurate predictions or flawed outcomes, potentially compromising the integrity of the entire trial.
Technical and access barriers
As AI is still a new and advancing technology, some researchers may have problems accessing it - both in terms of cost and resource availability. Implementing AI is not as simple as downloading a piece of software. It requires advanced infrastructure, significant expertise, and the ability to integrate with existing technology systems and processes. Smaller organizations may not have the capacity, resources, or funding to do this.
A knock-on effect of this is that research organizations are not performing equally. These disparities in access to AI technologies create inequalities in clinical trial processes, which also impact who benefits and how they benefit from the results.
Future directions and challenges
AI is not going away anytime soon. If anything, it will keep gaining prevalence in the world, including the clinical research landscape. The future of AI in clinical trials promises groundbreaking innovations and advancements poised to further improve efficiencies, accuracy, and inclusivity.
AI in wearable technology
While AI is already making a difference in the wearable tech we use every day, we expect to see it become more useful in the medical research space. AI techniques could be combined with wearable sensor devices to develop efficient, real-time participant surveillance systems capable of monitoring patients during the trial. This could reduce site visits and provide more frequent and reliable data, potentially speeding up the entire trial timeline.
AI integration into trial design
Clinical trial design can be time-consuming and complex, but data-driven AI tools may be able to completely improve and even revolutionize the design process. From preparation to execution, generative AI may be able to create synthetic datasets, predict trial outcomes, and optimize protocols in ways that have never been done before.
We also expect to see AI tools simulate complex scenarios to help researchers refine study parameters and reduce their reliance on expensive real-world trials.
Standardization of AI tools
With AI tools and technologies continuing to develop and mature, they are expected to become a central and key part of clinical research. This means tools and frameworks will be standardized to ensure consistent and reliable implementation across trials and research organizations. In the near future, we expect regulatory bodies to develop clear guidelines that make it easier for organizations to adopt AI solutions.
Summary
Once just a pipedream, artificial intelligence has quickly become a reality. And in the world of clinical research, this technology is set to completely revolutionize how clinical trials are performed. From streamlining patient recruitment to optimizing trial design and enhancing data analysis, AI is already making its mark in clinical research.
FAQs
Can AI replace human researchers in clinical trials?
AI cannot fully replace human researchers in a clinical trial. While AI can enhance efficiency and improve the clinical trial process, it should only be used to support human efforts. Tasks that can be automated, such as data analysis, participant recruitment, and patient monitoring can all be performed using AI, but these tasks still require a human to oversee them. From interpreting results to making ethical decisions and managing complex elements of a clinical trial, humans still play a pivotal role in clinical research.
Will AI make clinical trials faster and better?
AI has the potential to speed up and improve clinical trials by optimizing processes and making the trial process more efficient. It can make clinical trials run faster by automating time-consuming or mundane tasks and quickly analyzing vast datasets. AI can make clinical trials better by identifying patterns, predicting outcomes, and facilitating personalized medicines to improve data accuracy and accelerate the development of new treatments.